Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA Approves 1st Non-Opioid Pain Medicine in 20 Years
FDA approves first new type of pain medication in 25 years
The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a 50-milligram prescription pill that’s taken every 12 hours after a larger starter dose.
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids.
What Is Journavx? First Pain Medication Approved by FDA in Over Two Decades
This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.
FDA, migraine and Symbravo
US FDA approves Axsome Therapeutics' migraine drug
The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.
Axsome Therapeutics announces FDA approval of Symbravo
Axsome Therapeutics (AXSM) announced that the U.S. FDA has approved Symbravo for the acute treatment of migraine with or without aura in
FDA approves new migraine treatment SYMBRAVO
NEW YORK - Axsome Therapeutics, Inc. (NASDAQ:AXSM), a $5.28 billion biopharmaceutical company with impressive 51% revenue growth over the last twelve months, announced the U.S. Food and Drug Administration (FDA) has approved SYMBRAVO®,
type 2 diabetes, chronic kidney disease and FDA
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease,
US FDA approves Novo Nordisk's Ozempic to cut risk of diabetic kidney disease progression
The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes patients with chronic kidney disease (CKD),
FDA Approves Ozempic to Protect Kidneys in Patients With Type 2 Diabetes
Doctors already use Ozempic to manage type 2 diabetes and reduce the risk of heart disease in patients with diabetes. This move, as reported by The Times, was based on research sh
Recall raised to highest risk level by FDA. What to know
Chocolate Recall Update As FDA Sets Highest Risk Level for 9 States
A recall which was issued across nine states has now been given the highest risk classification by the federal agency.
FDA reclassifies Lay’s potato chips recall to the highest risk level, warning the chips could cause ‘serious adverse health consequences or death’
The FDA has raised the risk level on a recall of Lay’s potato chips to the highest level, warning the recalled product could cause death. The chips were originally recalled last month for containing undeclared milk.
Frito Lay's Classic Potato Chips: Recall raised to highest risk level by FDA. What to know
The Food and Drug Administration just raised the recall level of Lay’s Classic Potato Chips to the highest risk classification. Frito Lay issued a recall on Dec. 16 through the FDA for over 6,000 bags of Lay's Classic Potato Chips that contained "undeclared milk.
11h
US FDA Identifies Cybersecurity Risks in Certain Patient Monitors
(Reuters) - The U.S. Food and Drug Administration (FDA) said on Thursday it had identified three cybersecurity risks ...
1d
on MSN
Broccoli Recall Update as FDA Sets Highest Risk Level Over Bacteria Fears
Broccoli florets sold in Walmart stores across 20 states that were recalled over bacterial contamination fears have been ...
2d
on MSN
Trump admin's FDA withdraws proposed federal rule to ban menthol cigarettes
Trump's FDA moved to squash a proposed rule to ban menthol cigarettes just one day after the president was sworn in, angering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Crash at Reagan airport
Los Angeles wildfire updates
Cause of death revealed
Asteroid may hit Earth
Signs education orders
Michigan priest loses license
Ex-worker admits to theft
Blames DEI for crash
Hamas confirms death
Accused of sexual misconduct
Day 2 of Senate hearing
Wildfire erupts in NC
DOJ weighs dropping case?
Deputy shooting sentence
'As Tears Go By' singer dies
2 more victims in indictment
S3 release date revealed
US economy grew 2.3%
Searching for joyriders
Hamas frees more hostages
Ebola outbreak in Uganda
Senate confirmation hearing
Weekly jobless claims fall
Nashville bids for franchise
Ground stop amid IT outage
First spacewalk together
Syria’s transitional pres
Shiffrin finishes 10th
Partners w/ US national labs
DOJ sues to block deal
Related topics
Trump
Washington
United States
Food and Drug Administration
Journavx
Feedback